STAT+: Roche inks drug discovery deal with Chinese biotech, focused on molecular glue medicines

Roche is digging deeper into the biotech industry in China, striking a new partnership with a drug startup there. But rather than licensing the startup’s clinical-stage medicines, Roche is enlisting it to discover new ones, signaling a potential…

Read the full story at STAT ↗